ID   HIE1
AC   CVCL_C0IA
DR   Wikidata; Q112929725
RX   PubMed=11876951;
CC   Population: Chinese.
CC   Doubling time: 22-24 hours (PubMed=11876951).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=11876951).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=11876951; DOI=10.3760/cma.j.issn.0253-2727.2000.02.002;
RA   Han J.-L., Han M.-Z., Liu S.-H., Li C., Zhou Z., Li X., Yan H.,
RA   Cui W., Liu J., Mi Y.;
RT   "Establishment and biological characteristics of a novel
RT   erythroleukemia cell line (HIE1).";
RL   Zhonghua Xue Ye Xue Za Zhi 21:6-9(2000).
//